All In Biotech

Drug Trial Radar · NCT06783114

A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults

A Clinical Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults (REHAB-1)

Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 254 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

254

Planned (sponsor's estimate)

Start

Sep 14, 2024

Primary completion

Sep 30, 2026

Study completion Sep 30, 2026

Sponsor

Sponsor type
Industry
First posted
Jan 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, multi-center phase II/III study to evaluate the efficacy and safety of Recombinant Botulinum Toxin Type A (YY001) for injection in the treatment of upper limb spasticity in adults

Conditions

  • Upper Limb Spasticity

Interventions

  • Recombinant Botulinum Toxin Type A for injection (YY001)Biological

    Single treatment, prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl), intramuscular injection, the total injection dose is 200-400 U.

  • BOTOX®Biological

    Single treatment, prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl), intramuscular injection, the total injection dose is 200 U.

  • PlaceboBiological

    Single treatment, prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl), intramuscular injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Modified Ashworth Scale (MAS) Score of Primary Target Clinical Pattern at Week 4Time frame: Week 4 after treatment

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Recruiting

  • The Second People's Hospital of Hefei

    Hefei, Anhui, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Chongqing Traditional Chinese Medicine Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-sen Memorial Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Shenzhen Second People's Hospital

    Shenzhen, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Henan University

    Kaifeng, Henan, China · Recruiting

  • RenMin Hospital Of Wuhan University

    Wuhan, Hubei, China · Recruiting

  • Huai'an First People's Hospital

    Huai'an, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China · Recruiting

  • The Fourth Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China · Recruiting

  • Xuzhou Medical University Affiliated Hospital

    Xuzhou, Jiangsu, China · Recruiting

  • Qilu Hospital of Shandong University

    Qingdao, Shandong, China · Recruiting

  • Zibo Municipal Hospital

    Zibo, Shandong, China · Recruiting

  • Rui Jin Hospital of Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanghai Fudan University HuaShan Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Yangzhi Affiliated Rehabilitation Hospital of Tongji University

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China · Recruiting

  • Shanxi provincial people's Hospital

    Taiyuan, Shanxi, China · Recruiting

  • West China Hospital,Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • The Second Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.